Basic Information
Basic information for LINC01876-210-21aa
Peptide Name LINC01876-210-21aa
Genome Position chr2:156021614-156021676[-]
Species Human
Peptide Sequence MSVASGCPQFGISTLSKSELL
Peptide Length 21
Unique No (LINC01876-201-21aa,LINC01876-209-21aa,LINC01876-211-21aa,LINC01876-212-21aa,LINC01876-213-21aa)
Grand Average of Hydropathicity 0.5286
Relative Molecular Mass 2515.83
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000226383;LINC01876
Transcript ID/Name ENST00000657334;LINC01876-210
Transcript Length 1770
Coding Ability 0.3847
DNA Sequence Corresponding to Peptide ATGAGTGTTGCTTCAGGTTGCCCTCAATTTGGTATCAGTACCCTCAGTAAATCAGAGTTGCTG
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :